Nasal Vaccine Gets Approval for Booster Doses
Bharat Biotech’s intranasal vaccine will be used in India’s Covid-19 vaccination programme. On December 23, 2022, Union Health Minister Mansukh Mandaviya said the vaccine was...
Category : HEALTHCARE
Glenmark Pharma Signs Settlement Agreement with Pfizer Over Cancer Drug
On Tuesday, Glenmark Pharmaceuticals said it had reached a settlement with Pfizer over a cancer treatment drug.The Mumbai-based drugmaker and its US subsidiary signed a...
Aurobindo Pharma Arm Gets USFDA Approval for Fungal Infection Treatment Injection
Aurobindo Pharma said on Friday that its wholly-owned subsidiary Eugia Pharma Specialties had received final approval from the United States Food and Drug Administration (USFDA)...
Bajaj Healthcare Completes USFDA Pre-Approval Inspection of Vadodara Facility
On Friday, Bajaj Healthcare Ltd said it has successfully completed a pre-approval inspection by US health regulators at its active pharmaceutical ingredient plant in Vadodara,...
Pfizer Says COVID-19 Vaccine Will Cost $110-$130 Per Dose
Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the US government stops buying the vaccine, but the drugmaker said...
Lupin Partners with Global Agencies to Support TB Prevention Treatment Initiatives
On Friday, Pharmaceutical company Lupin said that it has partnered with Unitaid, the Aurum Institute, the Clinton Health Access Initiative (CHAI) and other global procurement...
Glenmark Pharma Launches Drug to Treat Type 2 Diabetes in Adults
Glenmark Pharmaceuticals announced on October 6 that it had become the first company in India to launch thiazolidinedione (lobeglitazone) for adults with type 2 diabetes....
India’s First Indigenous Cervical Cancer Vaccine to be Available Soon
India’s first locally produced quadrivalent human papillomavirus (HPV) vaccine against cervical cancer will be available within months. The vaccine will be available to people for...
Alembic Pharma Gets USFDA Nod for Chlorthalidone, Blood Pressure Drug
On Monday, Alembic Pharmaceuticals said it had received regulatory approval from the US Food and Drug Administration (USFDA) for chlorthalidone tablets used to treat high...
DCGI Approves AstraZeneca’s Drug for Treatment of High-risk Early Breast Cancer
On Friday, the Drugs Controller General of India (DCGI) has given its market approval to the drug Lynparza (Olaparib) as a monotherapy for the adjuvant...